Paricalcitol

Paricalcitol is a lipid of Sterol Lipids (ST) class. Paricalcitol is associated with abnormalities such as Vitamin D Deficiency. The involved functions are known as Hypertrophy, Left Ventricular. Paricalcitol often locates in Blood.

Cross Reference

Introduction

To understand associated biological information of Paricalcitol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Paricalcitol?

Paricalcitol is suspected in Vitamin D Deficiency and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Paricalcitol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Paricalcitol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Paricalcitol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Paricalcitol?

There are no associated biomedical information in the current reference collection.

What genes are associated with Paricalcitol?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Paricalcitol?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Paricalcitol

Download all related citations
Per page 10 20 50 100 | Total 375
Authors Title Published Journal PubMed Link
Mizobuchi M et al. Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. 2007 Kidney Int. pmid:17597697
Joy MS et al. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. 2007 J Manag Care Pharm pmid:17605511
Fryer RM et al. Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 mice. 2007 Nephron Physiol pmid:17622742
Repo JM et al. Paricalcitol aggravates perivascular fibrosis in rats with renal insufficiency and low calcitriol. 2007 Kidney Int. pmid:17667981
Chertow GM et al. Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate. 2006 Clin J Am Soc Nephrol pmid:17699221
Wu-Wong JR et al. Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells. 2007 Am. J. Physiol. Renal Physiol. pmid:17715259
Huybers S and Bindels RJ Vascular calcification in chronic kidney disease: new developments in drug therapy. 2007 Kidney Int. pmid:17805315
Brancaccio D et al. Vitamin D receptor activator selectivity in the treatment of secondary hyperparathyroidism: understanding the differences among therapies. 2007 Drugs pmid:17883283
Andress D Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease. 2007 Drugs pmid:17883284
Ross EA et al. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis. 2008 Am. J. Nephrol. pmid:17914251